Micro Life Sciences

Micro Life Sciences is an India-based private medical technology company best known as the parent company of Meril. The group develops, manufactures, and commercializes a broad portfolio of medical devices and diagnostics spanning cardiovascular intervention, structural heart, orthopedics, endo-surgery, robotics, ENT, and in vitro diagnostics. Its flagship products include the Myval transcatheter heart valve series for TAVR and the MyClip transcatheter edge-to-edge repair system for mitral valve repair, alongside a larger portfolio of implants, consumables, and diagnostic products. The company has significant manufacturing and R&D operations in Gujarat, India, and sells into domestic and export markets. Micro Life Sciences is privately held, backed by investors including Warburg Pincus and ADIA, and has been discussed as a potential IPO candidate but is not publicly listed as of April 8, 2026.